These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1517064)

  • 1. Supplementation of polyunsaturated fatty acids in multiple sclerosis.
    Gallai V; Sarchielli P; Trequattrini A; Murasecco D
    Ital J Neurol Sci; 1992 Jun; 13(5):401-7. PubMed ID: 1517064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary interventions for multiple sclerosis.
    Farinotti M; Simi S; Di Pietrantonj C; McDowell N; Brait L; Lupo D; Filippini G
    Cochrane Database Syst Rev; 2007 Jan; (1):CD004192. PubMed ID: 17253500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory and therapeutic effects of Hot-nature diet and co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients.
    Rezapour-Firouzi S; Arefhosseini SR; Mehdi F; Mehrangiz EM; Baradaran B; Sadeghihokmabad E; Mostafaei S; Fazljou SM; Torbati MA; Sanaie S; Zamani F
    Complement Ther Med; 2013 Oct; 21(5):473-80. PubMed ID: 24050582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis.
    Mehta LR; Dworkin RH; Schwid SR
    Nat Clin Pract Neurol; 2009 Feb; 5(2):82-92. PubMed ID: 19194388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyunsaturated fatty acids in multiple sclerosis therapy.
    Wergeland S; Torkildsen Ø; Bø L; Myhr KM
    Acta Neurol Scand Suppl; 2012; (195):70-5. PubMed ID: 23278660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyunsaturated fatty acids in the low-birth-weight infant.
    Friedman Z
    Semin Perinatol; 1979 Oct; 3(4):341-61. PubMed ID: 395645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of fatty acids in the treatment of ADHD.
    Chalon S
    Neuropharmacology; 2009 Dec; 57(7-8):636-9. PubMed ID: 19715711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polyunsaturated fatty acids for multiple sclerosis treatment: scientific evidence].
    Kong-González M; Pérez-Cortéz JG; Hernández-Girón C; Macías-Morales N; Flores-Aldana M
    Medwave; 2015 Jan; 15(1):e6062. PubMed ID: 25628005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyunsaturated fatty acids and colchicine in multiple sclerosis.
    Br Med J; 1979 Feb; 1(6160):411-2. PubMed ID: 761034
    [No Abstract]   [Full Text] [Related]  

  • 10. Polyunsaturated fatty acids in multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1979 Mar; 1(6164):683. PubMed ID: 435724
    [No Abstract]   [Full Text] [Related]  

  • 11. Trial of polyunsaturated fatty acids in non-relapsing multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1977 Oct; 2(6092):932-3. PubMed ID: 334337
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolic aspects of multiple sclerosis].
    Neu IS
    Wien Med Wochenschr; 1985 Jan; 135(1-2):20-2. PubMed ID: 3976233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyunsaturated fatty acids and colchicine in multiple sclerosis.
    Horrobin DF; Botez T; Botez MI
    Br Med J; 1979 Jan; 1(6157):199-200. PubMed ID: 421025
    [No Abstract]   [Full Text] [Related]  

  • 14. Polyunsaturated fatty acid (fish or evening primrose oil) for schizophrenia.
    Joy CB; Mumby-Croft R; Joy LA
    Cochrane Database Syst Rev; 2000; (2):CD001257. PubMed ID: 10796622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antioxidants and polyunsaturated fatty acids in multiple sclerosis.
    van Meeteren ME; Teunissen CE; Dijkstra CD; van Tol EA
    Eur J Clin Nutr; 2005 Dec; 59(12):1347-61. PubMed ID: 16118655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyunsaturated Fatty Acids and Chronic Pain: A Systematic Review and Meta-analysis.
    Prego-Dominguez J; Hadrya F; Takkouche B
    Pain Physician; 2016; 19(8):521-535. PubMed ID: 27906932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety considerations of polyunsaturated fatty acids.
    Eritsland J
    Am J Clin Nutr; 2000 Jan; 71(1 Suppl):197S-201S. PubMed ID: 10617971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyunsaturated fatty acids and the risk of multiple sclerosis.
    Bjørnevik K; Chitnis T; Ascherio A; Munger KL
    Mult Scler; 2017 Dec; 23(14):1830-1838. PubMed ID: 28156186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential fatty acids in mothers and their neonates.
    Hornstra G
    Am J Clin Nutr; 2000 May; 71(5 Suppl):1262S-9S. PubMed ID: 10799400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1978 Nov; 2(6149):1390-1. PubMed ID: 363236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.